Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

5
Raytheon: Operational Strength Creates Value For Shareholders

18h seekingalpha
The share price decline after second quarter earnings is providing an excellent opportunity to acquire shares below fair value.
LMT NOC NSM RTN OA

1
Recent Underperformance Makes Northrop Grumman An Interesting Opportunity

23h seekingalpha
Since peaking near all-time highs in April, shares of Northrop Grumman (NYSE:NOC) have dropped almost 19%.
LMT NOC OA

1
Northrop Grumman Offers Good Value As Currently Priced

2018-08-20 seekingalpha
As I wrote in a previous article, Lockheed Martin (LMT) is my favorite name in defense sector. Another defense stock that I have been interested in for some time Northrop Grumman (NOC). The Aerospace & Defense ETF (ITA) has been one of the hottest investments over the past five years. Within that ETF, Northrop Grumman has performed very well.
LMT NOC VALU OA

1
China designs spacecraft to extend lifespan of satellites

2018-08-13 technology.inquirer.net
BEIJING – Chinese satellite experts are designing a new type of spacecraft that will be capable of moving a de-orbiting satellite back into its intended orbit, thus extending its period of service.
OA

7
Raytheon names Sally Sullivan VP, US Business Development and Ed Fortunato, VP, Government Relations

2018-08-02 asdnews
Raytheon Company (NYSE: RTN) has named Sally Sullivan vice president of U.S. Business Development, and Ed Fortunato vice president of Government Relations. Sullivan and Fortunato will report to John D. Harris II , vice president, Business Development for Raytheon Company, and Chief Executive Officer, Raytheon International , Inc.
MANT HON NOC GD HON RTN CSRA OA

1
Northrop Grumman: Looks Attractive After Earnings Pullback

2018-07-27 seekingalpha
The Orbital ATK deal was finalized in the second quarter, and interest expenses increased $200 million annually.
LMT NOC RTN BA OA

1
The New Rockets Racing to Make Space Affordable

2018-07-26 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
LMT OA

1
Northrop Grumman (NOC) Q2 2018 Results - Earnings Call Transcript

2018-07-25 seekingalpha
Good day, ladies and gentlemen, and welcome to Northrop Grumman's second quarter 2018 conference call. Today's call is being recorded. My name is Jamie, and I will be your operator today. At this time, all participants are in listen-only mode.
LMT NOC OA

1
Northrop Grumman appoints UK and Europe executive

2018-07-25 janes
Northrop Grumman announced on 23 July that it had appointed Nick Chaffey as its Chief Executive for the United Kingdom and Europe.
NOC OA

2
Pfizer & Eli Lilly Obtain Potential Pain Alternative For Treating Osteoarthritis Pain

2018-07-24 seekingalpha
Pfizer and its partner Eli Lilly announced positive phase 3 results treating patients with osteoarthritis of the knee or hip using tanezumab.
PFE OA

1
Is Amazon's (AMZN) Jeff Bezos Helping Usher in the Next Space Race?

2018-07-21 zacks
Blue Origin is a privately funded aerospace manufacturer and spaceflight service company based in Kent, Washington, and is the brainchild of Amazon (AMZN - Free Report) CEO Jeff Bezos. Founded in 2000, the company aims to take private consumers to space.
LMT OA

1
OA / Orbital ATK, Inc. null

2018-07-19 sec.gov
UNITED STATES
OA

1
OA / Orbital ATK, Inc. null

2018-07-19 sec.gov
UNITED STATES
OA

1
Vista Outdoor Has More Upside Left

2018-07-19 seekingalpha
Sales and margins should rebound due to bottoming out of ammunition sales and decreased commodity input cost pressures.
VSTO OA

16
Northrop's CEO to Depart Next Year as Defense Giant Elevates COO - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
NOC GEC GE GNE OA

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 68557N103